1 asset in Isolated Optic Nerve Hypoplasia
Therapeutic assets addressing Isolated Optic Nerve Hypoplasia, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Setmelanotide Isolated Optic Nerve Hypoplasia | Rhythm Pharmaceuticals, Inc. | P3 | B (60) |